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The main reservation I have about this book is the 
title. It is not a textbook or overview of two large 
disciplines that the breadth of ‘Biochemistry and 
Neurology’ might suggest, but a transcription of the 
conference organised by the Neurochemical Group of 
the Biochemical Society at Nottingham University, 
17-18 April, 1975. Part I is concerned with dyskine- 
sias; Part II with epilepsy. Neither the neurological 
disorders nor the biochemical correlates are treated 
comprehensively, but one has to draw lines some- 
where. Migraine and multiple sclerosis apart, 
dyskinesias and epilepsy probably account for the 
greatest percentage of neurological disorders in 
industrialised countries. The tremendous research 
efforts devoted to neurobiological problems have 
given us good reason to believe that there are at least 
some areas where we are close to understanding CNS 
dysfunction. Anyone who has witnessed the mira- 
culous alleviation of Parkinsonian rigidity by treat- 
ment with L-dihydroxyphenylalanine, more recently 
combined with a peripheral Dopa-decarboxylase 
inhibitor, must surely be convinced of the value of a 
biochemical approach to such problems. The use of 
antiepileptic drugs is a major therapeutic advance 
even though the causes of epilepsy and the mechanism 
of action of the various drugs are not well understood. 
Human post-mortem brains, although of limited 
availability, are providing increasingly useful material. 
The low dopamine concentrations in the basal 
ganglia of Parkinsonian patients lead directly to the 
use of LDopa. The current status of L-Dopa therapy, 
and its alternatives, is discussed in considerable detail. 
Supersensitivity of dopaminergic receptors, and the 
possibility that two types of dopamine receptors are 
present in the CNS are given an interesting and up-to- 
date treatment. The old hypothesis that Huntington’s 
chorea was due to overactivity of dopaminergic 
neurons has had to be abandoned. Post-mortem 
material from these patients has not proved so 
rewarding as that from Parkinsonian’s. Decreases in
y-aminobutyric acid, acetylcholine and, more 
recently, substance P,have been found in the basal 
ganglia. Since we are told that up to 50% of the 
neurons, large and small, may be lost, these findings 
are not perhaps o surprising. The interpretation of 
biochemical data from post-mortem aterial must, 
therefore, be considered in relation to anatomical 
parameters. The plasticity of the CNS might allow 
extensive primary and secondary changes to occur 
before the full clinical syndrome becomes apparent. 
Furthermore, besides post-mortem changes, the 
nature of the events immediately prior to death 
itself may induce changes in specific biochemical 
pathways. 
In the case of epilepsy which, like migraine, can be 
caused by a wide variety of insults to the CNS, the 
nature of the basic lesion is not known and the 
symptoms may only appear intermittently. Townsend 
states that ‘The trouble with epilepsy is that most of 
the time it isn’t there!’ and biochemists are rightly 
cautious of systems which contain such independent 
variables. There are good general introductions to the 
clinical and biochemical aspects of human epilepsy. 
The use of metal implants to induce seizures in 
experimental nimals, and the value of combining 
biochemical, pharmacological and electrophysiological 
studies is brought out by the more detailed presenta- 
tions., 
This is a good book for the specialist. The bio- 
chemical aspects covered are mainly related to 
chemical neurotransmission a d naturally, therefore, 
a great deal of pharmacological data is presented. 
This conference was widely held to be a great success 
and the lucid introductory chapters and pertinent 
discussion periods certainly stimulate alively apprecia- 
tion of the research topics. The overall esson seems to 
be that we need to know more about the functional 
anatomy.of the human brain; more about the precise 
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pathways of neurons utilizing the established trans- 
mitters and more about different ransmitters and 
their receptors. Biochemists may note with some 
alarm that drugs used to treat schizophrenia (pheno- 
thiazines, butyrophenones) or LDopa itself can 
induce dyskinesias. Nevertheless, the cover of this 
book, which displays a partly dissected human head 
surrounded by a halo of transmitters (dopamine, 
GABA and something else), is a very modest statement 
of the art as it stands at present. 
J. J. Barlow 
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This book is the first in a series on the ageing 
brain. In this volume there are seven chapters that 
mostly concern morphological nd biochemical 
aspects of normal brain. 
The contributors are in agreement that there are 
correlations between mental deterioration i  the 
elderly and morphological changes. Although some 
authors put emphasis on the importance of senile 
plaques and neurotibrillary degeneration the Scheibels 
conclude that the deterioration of psychomotor 
function with advancing years is in part a function of 
the quality of neuropil. Since senile plaques may 
contain an immunoglobulin-derived ‘core’ of amyloid 
this may be indicative of a humoral involvement in 
the pathogenesis of the aging brain. 
The deposition and properties of lipofuscin and 
neuromelanin are reviewed in considerable detail. 
Both pigments may be derived from lysosomes, 
possibly due to abnormal autoxidation while neuro- 
melanin accumulates characteristically in catechol- 
amine-containing eurones. 
There are very few original papers dealing with 
neurochemical changes either the ageing human or 
primate brain. Despite this, the chapter on this topic 
accounts for almost one-third of the book. Much of 
the extraneous material could have been either omitted 
or nossibly discussed in an additional chapter on 
‘Theories of brain ageing’. As more becomes known 
about the ageing human brain many neurochemists 
will be debating the relevance to functional and 
organic brain disorders of the elderly of studies on 
laboratory animals. This is because there is a great 
increase in neocortical development in man as 
compared with most experimental nimals. 
David M. Bowen 
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